According to US Department of Health and Human Services official Robert Kadlec, the US government's current supply of Gilead Sciences' COVID-19 treatment remdesivir will run out at the end of the month, reported CNN.
The government's last shipment of the drug will go out the week of June 29, and while Gilead is ramping up to manufacture more, it remains unclear how much will be available this summer.
"Right now, we're waiting to hear from Gilead, what is their expected delivery availability of the drug as we go from June to July," Kadlec said, adding "we're kind of not in negotiations, but in discussions with Gilead as they project what the availability of their product will be."
Kadlec indicated that Gilead has given a "general range" of product delivery for July and August, which then "significantly expands beginning in September, October, and through the fall as they kind of open the spigot of their production and processing."
The company has offered few public details, but it has said it plans to have more than 500,000 treatment courses available by October, and more than a million by December.
Kadlec added that the government has been working to help Gilead "with some of their supply chain challenges in terms of raw materials and being able to accelerate the process."